Pharm-Rx Dipyridamole USP

Dipyridamole contains NLT 98.0% and NMT 102.0% of dipyridamole (C₂₄H₄₀N₈O₄ ), calculated on the dried basis.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

• USP Dipyridamole RS
• USP Dipyridamole Related Compound A RS
• 2,2′-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-
• 2-yl]azanediyl}diethanol.
• C₂₅H₄₀N₈O₂ 484.64
• USP Dipyridamole Related Compound B RS
• 2,2′,2′′,2′′′,2′′′′,2′′′′′-{[8-(Piperidin-1-yl)pyrimido[5,4-d]
• pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol.
• C₂₃H₄₀N₈O₆ 524.61
• USP Dipyridamole Related Compound C RS
• 2,2′-{[6-Chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]
• pyrimidin-2-yl]azanediyl}diethanol.
• C₂₀H₃₀ClN₇O₂ 435.95
• USP Dipyridamole Related Compound D RS
• 2,2′-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)
• pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol.
• C₂₂H₃₆N₈O₃ 460.57
• USP Dipyridamole Related Compound E RS
• 2,2′,2′′,2′′′-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]
• pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol.
• C₂₄H₄₀N₈O₄ 504.63
• USP Dipyridamole Related Compound F RS
• 2,2′,2′′,2′′′-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-
• yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))
• tetraethanol.
• C₂₁H₃₆N₈O₅ 480.56